deferoxamine has been researched along with Respiratory Distress Syndrome in 8 studies
Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.
Respiratory Distress Syndrome: A syndrome characterized by progressive life-threatening RESPIRATORY INSUFFICIENCY in the absence of known LUNG DISEASES, usually following a systemic insult such as surgery or major TRAUMA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To review the adverse effects and risks of deferoxamine for the treatment of iron poisoning." | 8.79 | Risks of parenteral deferoxamine for acute iron poisoning. ( Howland, MA, 1996) |
| "To review the adverse effects and risks of deferoxamine for the treatment of iron poisoning." | 4.79 | Risks of parenteral deferoxamine for acute iron poisoning. ( Howland, MA, 1996) |
| "The drug of choice for the treatment of iron poisoning is desferrioxamine, though the best route of administration, dose, and duration of treatment are unclear." | 1.28 | Pulmonary toxic effects of continuous desferrioxamine administration in acute iron poisoning. ( Adamson, IY; Bowden, DH; Kowalski, S; Sienko, A; Tenenbein, M, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (62.50) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Atas, B | 1 |
| Caksen, H | 1 |
| Tuncer, O | 1 |
| Oner, AF | 1 |
| Kirimi, E | 1 |
| Akbayram, S | 1 |
| Ritter, C | 1 |
| da Cunha, AA | 1 |
| Echer, IC | 1 |
| Andrades, M | 1 |
| Reinke, A | 1 |
| Lucchiari, N | 1 |
| Rocha, J | 1 |
| Streck, EL | 1 |
| Menna-Barreto, S | 1 |
| Moreira, JC | 1 |
| Dal-Pizzol, F | 1 |
| Cross, CE | 1 |
| van Asbeck, BS | 1 |
| Halliwell, B | 1 |
| Howland, MA | 1 |
| Tenenbein, M | 1 |
| Kowalski, S | 1 |
| Sienko, A | 1 |
| Bowden, DH | 1 |
| Adamson, IY | 1 |
| Chan, KW | 1 |
| Bond, M | 1 |
| Fernandez, W | 1 |
| Anderson, KJ | 1 |
| Rivers, RP | 1 |
| Fisher, EA | 1 |
| McLachlan, DR | 1 |
| Kruck, TP | 1 |
| Mustard, RA | 1 |
1 review available for deferoxamine and Respiratory Distress Syndrome
| Article | Year |
|---|---|
Risks of parenteral deferoxamine for acute iron poisoning.
Topics: Administration, Oral; Antidotes; Communicable Diseases; Deferoxamine; Ear Diseases; Eye Diseases; Hu | 1996 |
7 other studies available for deferoxamine and Respiratory Distress Syndrome
| Article | Year |
|---|---|
Acute respiratory distress syndrome due to overdose desferrioxamine: report of a child.
Topics: Deferoxamine; Drug Overdose; Female; Humans; Infant; Respiratory Distress Syndrome; Siderophores | 2005 |
Effects of N-acetylcysteine plus deferoxamine in lipopolysaccharide-induced acute lung injury in the rat.
Topics: Acetylcysteine; Animals; Bronchoalveolar Lavage Fluid; Deferoxamine; Disease Models, Animal; Interle | 2006 |
More antioxidants in sepsis: still paved with uncertainties.
Topics: Acetylcysteine; Animals; Bronchoalveolar Lavage Fluid; Deferoxamine; Disease Models, Animal; Humans; | 2006 |
Pulmonary toxic effects of continuous desferrioxamine administration in acute iron poisoning.
Topics: Acute Disease; Adult; Deferoxamine; Female; Humans; Infusions, Intravenous; Iron; Lung; Male; Poison | 1992 |
Desferrioxamine in acute iron poisoning.
Topics: Child; Deferoxamine; Humans; Infusions, Intravenous; Iron; Respiratory Distress Syndrome; Thalassemi | 1992 |
Desferrioxamine in acute iron poisoning.
Topics: Deferoxamine; Humans; Infant; Iron; Male; Respiratory Distress Syndrome | 1992 |
Development of an intravenous desferrioxamine mesylate treatment protocol for swine: monitoring of desferrioxamine and metabolites by high-performance liquid chromatography.
Topics: Anesthesia; Animals; Chromatography, High Pressure Liquid; Deferoxamine; Female; Half-Life; Injectio | 1990 |